Type of adverse event | DPQ and efavirenz-based ART regimen N = 160 | DPQ and nevirapine-based ART regimen N = 61 |
---|---|---|
na (%) [#]b | na (%) [#]b | |
Serious adverse events (SAEs) | 8 (5.0), [10] | 2 (3.3), [2] |
Adverse event(s) of special interest (AESI) | 54 (33.8), [54] | 15 (24.6), [15] |
Fridericia corrected QT prolongationc | 48 (30.0) | 8 (13.1) |
Palpitations | 4 (2.5) | 2 (3.3) |
Dizziness | 2 (1.3) | 2 (3.3) |
Urticaria | 0 | 1 (1.6) |
Itchiness | 0 | 1 (1.6) |
Chest pain | 0 | 1 (1.6) |
Drug-related adverse events (SAEs) | ||
Not related | 7 (4.4), [9] | 2 (3.3), [2] |
Possibly related | 1 (0.6), [1] | 0 |
Probably related | 0 | 0 |
Definitely related | 0 | 0 |
Drug-related adverse events (AESI) | ||
Not related | 1 (0.6), [1] | 4 (6.6) [4] |
Possibly related | 5 (3.1), [5] | 3 (4.9), [3] |
Probably related | 48 (30.0), [48] | 8 (13.1), [8] |
Definitely related | 0 | 0 |